ATRC
Price
$57.53Alerts
Change
+$1.27 (+2.26%)
Updated
Nov 11 closing price
Capitalization
2.98B
103 days until earnings call
Intraday BUY SELL Signals
IRMD
Price
$86.58Alerts
Change
-$0.14 (-0.16%)
Updated
Nov 11 closing price
Capitalization
1.1B
84 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ATRC vs IRMD

ATRC vs IRMD Comparison Chart in %
View a ticker or compare two or three
VS
ATRC vs. IRMD commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRC is a Hold and IRMD is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ATRC with price predictions
Nov 11, 2026

ATRC in upward trend: price rose above 50-day moving average on November 11, 2026

ATRC moved above its 50-day moving average on November 11, 2026 date and that indicates a change from a downward trend to an upward trend. In 35 of 46 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +9.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATRC advanced for three days, in 212 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

The Aroon Indicator entered an Uptrend today. In 182 of 244 cases where ATRC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.

Bearish Trend Analysis

The 10-day RSI Indicator for ATRC moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 23 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.

The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ATRC as a result. In 70 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

The Moving Average Convergence Divergence Histogram (MACD) for ATRC turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 38 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATRC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

ATRC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. ATRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.766) is normal, around the industry mean (4.964). ATRC's P/E Ratio (266.091) is considerably higher than the industry average of (40.591). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (4.869) is also within normal values, averaging (56.876).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATRC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for IRMD with price predictions
Nov 11, 2026

IRMD's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for IRMD turned positive on November 06, 2026. Looking at past instances where IRMD's MACD turned positive, the stock continued to rise in 42 of 53 cases over the following month. The odds of a continued upward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IRMD's RSI Oscillator exited the oversold zone, 12 of 16 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on IRMD as a result. In 86 of 114 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.

IRMD moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRMD advanced for three days, in 194 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

IRMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 203 of 260 cases where IRMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for IRMD crossed bearishly below the 50-day moving average on October 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is 41 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. IRMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.847) is normal, around the industry mean (4.142). P/E Ratio (47.685) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.180) is also within normal values, averaging (11.253). Dividend Yield (0.009) settles around the average of (0.011) among similar stocks. P/S Ratio (12.315) is also within normal values, averaging (40.124).

FUNDAMENTALS RATINGS
ATRC vs IRMD: Fundamental Ratings
ATRC
IRMD
OUTLOOK RATING
1..100
8114
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
10020
SMR RATING
1..100
8841
PRICE GROWTH RATING
1..100
3656
P/E GROWTH RATING
1..100
755
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IRMD's Valuation (85) in the Medical Specialties industry is in the same range as ATRC (92). This means that IRMD’s stock grew similarly to ATRC’s over the last 12 months.

IRMD's Profit vs Risk Rating (20) in the Medical Specialties industry is significantly better than the same rating for ATRC (100). This means that IRMD’s stock grew significantly faster than ATRC’s over the last 12 months.

IRMD's SMR Rating (41) in the Medical Specialties industry is somewhat better than the same rating for ATRC (88). This means that IRMD’s stock grew somewhat faster than ATRC’s over the last 12 months.

ATRC's Price Growth Rating (36) in the Medical Specialties industry is in the same range as IRMD (56). This means that ATRC’s stock grew similarly to IRMD’s over the last 12 months.

ATRC's P/E Growth Rating (7) in the Medical Specialties industry is somewhat better than the same rating for IRMD (55). This means that ATRC’s stock grew somewhat faster than IRMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRCIRMD
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
61%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 9 days ago
70%
Bullish Trend 4 days ago
73%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 2 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
78%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (ATRC: $57.53 vs. IRMD: $86.58)
Brand notoriety: ATRC and IRMD are both not notable
ATRC represents the Pharmaceuticals: Other, while IRMD is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ATRC: 58% vs. IRMD: 50%
Market capitalization -- ATRC: $2.98B vs. IRMD: $1.1B
ATRC [@Pharmaceuticals: Other] is valued at $2.98B. IRMD’s [@Medical/Nursing Services] market capitalization is $1.1B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $159.96B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.78B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRC’s FA Score shows that 1 FA rating(s) are green while IRMD’s FA Score has 1 green FA rating(s).

  • ATRC’s FA Score: 1 green, 4 red.
  • IRMD’s FA Score: 1 green, 4 red.
According to our system of comparison, IRMD is a better buy in the long-term than ATRC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRC’s TA Score shows that 4 TA indicator(s) are bullish while IRMD’s TA Score has 7 bullish TA indicator(s).

  • ATRC’s TA Score: 4 bullish, 5 bearish.
  • IRMD’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, IRMD is a better buy in the short-term than ATRC.

Price Growth

ATRC (@Pharmaceuticals: Other) experienced а -12.21% price change this week, while IRMD (@Medical/Nursing Services) price change was -2.26% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.07%. For the same industry, the average monthly price growth was +6.43%, and the average quarterly price growth was +22.77%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -4.63%, and the average quarterly price growth was -1.72%.

Reported Earning Dates

ATRC is expected to report earnings on Feb 23, 2027.

IRMD is expected to report earnings on Feb 04, 2027.

Industries' Descriptions

@Pharmaceuticals: Other (+2.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-2.76% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ATRC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with CERS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
+2.26%
CERS - ATRC
42%
Loosely correlated
+8.72%
SIBN - ATRC
41%
Loosely correlated
-0.64%
IRMD - ATRC
38%
Loosely correlated
-0.16%
ICUI - ATRC
38%
Loosely correlated
-2.11%
TMCI - ATRC
37%
Loosely correlated
+3.69%
More

IRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with PHG. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then PHG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
-0.16%
PHG - IRMD
48%
Loosely correlated
-0.69%
HBIO - IRMD
45%
Loosely correlated
+4.54%
ATEC - IRMD
44%
Loosely correlated
+5.00%
LIVN - IRMD
43%
Loosely correlated
-0.18%
TCMD - IRMD
42%
Loosely correlated
+1.92%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
STLU9.840.74
+8.17%
Volatility Shares 2x Stellar ETF (STLU)
NJAN59.950.63
+1.06%
Innovator Growth-100 Power Buffer ETF - January (NJAN)
JBBB46.770.03
+0.06%
Janus Henderson B-BBB CLO ETF (JBBB)
CBIL24.85N/A
N/A
Corgi 3-12 Month T-Bill ETF (CBIL)
UDN17.66-0.13
-0.73%
Invesco DB US Dollar Index Bearish Fund (UDN)